Senseonics Holdings, Inc. (NYSE:SENS) CFO Frederick T. Sullivan Purchases 124,933 Shares

Senseonics Holdings, Inc. (NYSE:SENS) CFO Frederick T. Sullivan purchased 124,933 shares of Senseonics stock in a transaction that occurred on Thursday, December 12th. The shares were bought at an average price of $0.38 per share, for a total transaction of $47,474.54. Following the completion of the transaction, the chief financial officer now owns 2,478,844 shares in the company, valued at $941,960.72. The trade was a 5.31 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Senseonics Price Performance

Shares of SENS stock opened at $0.46 on Friday. The firm has a market cap of $273.20 million, a P/E ratio of -3.53 and a beta of 0.77. Senseonics Holdings, Inc. has a fifty-two week low of $0.25 and a fifty-two week high of $0.75. The business’s 50 day moving average price is $0.33 and its 200-day moving average price is $0.38. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. StockNews.com assumed coverage on Senseonics in a research report on Tuesday. They set a “sell” rating on the stock. HC Wainwright restated a “buy” rating and set a $2.00 price target on shares of Senseonics in a research report on Friday, November 15th.

Institutional Investors Weigh In On Senseonics

Large investors have recently made changes to their positions in the business. FMR LLC grew its position in shares of Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after buying an additional 167,970 shares during the last quarter. GSA Capital Partners LLP bought a new stake in shares of Senseonics in the 3rd quarter worth approximately $117,000. Price T Rowe Associates Inc. MD grew its position in shares of Senseonics by 16.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after buying an additional 51,000 shares during the last quarter. Cubist Systematic Strategies LLC grew its position in shares of Senseonics by 25.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after buying an additional 85,501 shares during the last quarter. Finally, Symmetry Partners LLC bought a new stake in shares of Senseonics in the 3rd quarter worth approximately $164,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.